Participated · Series B · Jul 2026

Qureight provides two integrated products for pharmaceutical clinical trials: Workflow, which speeds imaging decision turnaround from about two weeks to 48 hours, and AI Lung, which constructs detailed models of airways and blood vessels from chest scans. The company has built a general-purpose foundation model of the chest that enables development of disease-specific deep learning models in one to two months. Qureight is running global clinical trials with partners including AstraZeneca, Bristol Myers Squibb, and several biotech firms. Founded in 2018, the company combines clinical leadership—co-founder and CEO Dr Muhunthan Thillai continues clinical work—with a senior technical team recruited from industry and academia. Financially, Qureight has raised a £1.5 million seed in 2022 and the recent $20 million Series B to support lab build-out, therapeutic-area expansion, and headcount growth.

Led · Series A · Jul 2026

Kord provides an API-based, end-to-end platform that combines identity verification, anti-money laundering (AML) and compliance checks, digital onboarding, document signing and payment processing into a single workflow. The platform also offers digital wallets and dedicated client accounts that enable regulated businesses to securely hold and manage client funds. Kord's APIs verify customer documents against multiple data sources to strengthen fraud prevention. Its customers include estate and letting agents, law firms, conveyancers and financial services companies. The company is regulated by the UK Financial Conduct Authority. Kord has raised £9 million to date, including the recent £6.4 million Series A, and plans to use the new capital to hire, accelerate product development and support customer growth.

Led · Series A · Jun 2026

Founded in 2021 by cousins Lara Rodgers and Nadia Simonds, Lune & Wild produces chef-crafted baby and children’s meals developed with paediatric dietitians and sourced from Soil Association–certified suppliers and high-welfare meat producers. The brand emphasizes flavour, variety and nutrition, and its recipes are positioned to optimise macro- and micronutrients for young children. Lune & Wild has doubled revenue each year since launch and sold over one million meals in the past 12 months, and holds a 4.8-star Trustpilot rating. Products are sold direct-to-consumer and through retail partners including Ocado.com, as well as in family clubs, cafés, delis, farm shops and 15 nurseries across London and the Home Counties. The company has a team of over 30 staff and plans to use fresh capital to increase production capacity, expand its retail footprint, and hire key personnel while maintaining its hands-on, chef-led approach.

Participated · Series A · Mar 2026

JAAQ operates a digital health engagement platform built around a clinically governed content library and an AI infrastructure layer. Its library contains more than 10,000 expert-led and lived-experience videos, and its AI-powered journeys are designed to integrate into existing user, patient, and customer digital experiences. The platform is deployed across organizations covering more than 1.5 million eligible lives. JAAQ offers both direct integration into partners' digital journeys and a hosted experience tailored to users. The company is investing in engineering to enable AI-native products that combine conversational AI with video to deliver personalized behavioral health pathways. Leadership additions include Alex Packham as CEO and Saurabh Johri leading product and technology development. JAAQ is expanding across the UK and U.S., targeting large employers, insurers, and healthcare systems, and recently raised $17 million to support that growth.

Participated · Equity · Jan 2026

Dragonfly AI has built a patented, neuroscience-led AI platform that predicts how audiences will notice, remember, and respond to advertising and other creative assets before they go live. Unlike data-trained generative AI systems, its biological algorithm does not rely on historical training data, helping brands avoid embedded model bias while receiving real-world attention and buyer-behavior predictions. The technology, originally developed in the neuroscience department at Queen Mary University of London, is now used by more than 70 global consumer brands, including Nestlé, PepsiCo, Unilever, Coca-Cola, and L’Oréal, and is integrated into enterprise workflows through partners such as CreativeX. Dragonfly AI is expanding its product suite with new Emotion & Memory metrics, broader video analysis, and deeper enterprise integrations via Dragonfly Connect. Proceeds from its latest financing will fund global expansion—particularly a larger U.S. commercial presence—along with growth of sales and customer-success teams. The company continues to invest in R&D under chief scientist and algorithm inventor Hamit Soyel while strengthening governance through the appointment of former Time Inc. executive Fiona Dent to its board.